Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We investigated the prevalence of sarcopenic obesity (SO) and its relationship with metabolic syndrome in a community-based elderly cohort in Korea. RESEARCH DESIGN AND METHODS: In this study, 287 men and 278 women aged 65 or older were recruited. Sarcopenia was defined as the appendicular skeletal muscle mass (ASM) divided by height squared (Ht2) (kg/m2) or by weight (Wt) (%) of <1 SD below the sex-specific mean for young adults. Obesity was defined as a visceral fat area ≥100 cm2. RESULTS: The prevalence of SO was 16.7% in men and 5.7% in women with sarcopenia defined by ASM/Ht2; however, it was 35.1% in men and 48.1% in women by ASM/Wt. Using ASM/Wt, the homeostasis model assessment of insulin resistance of subjects with SO was higher and they were at higher risk for metabolic syndrome (odds ratio [OR] 8.28 [95% CI 4.45–15.40]) than the obese (5.51 [2.81–10.80]) or sarcopenic group (2.64 [1.08–6.44]). CONCLUSIONS: SO defined by ASM/Wt was more closely associated with metabolic syndrome than either sarcopenia or obesity alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most clinical studies have reported that sarcopenic obesity is associated with metabolic syndrome [136,137,138].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [137]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Lim et al. observed a higher risk of metabolic syndrome among adults with sarcopenic obesity [defined using DXA-measured ALM/weight (%) and visceral fat area] [odds ratio (OR): 8.28, 95% CI: 4.45–15.40] than among those with obesity (OR: 5.51, 95% CI: 2.81–10.80) or sarcopenia (OR: 2.64, 95% CI: 1.08–6.44) in a cross-sectional study of 565 participants aged ≥65 years from the Korean Longitudinal”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [89]
In the citing paper
“In contrast, using the definition ALM/ht2, the ORs of metabolic syndrome were lower in the obesity group than in the sarcopenic obesity group (2.90 [95% CI: 1.28–6.57] vs. 4.80 [95% CI: 2.63–8.75]) (89).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [89]
In the citing paper
“Regarding body FM, the upper sex-specific cut-offs of 40% for females and 30% for males have been proposed as best predictors of mortality in the NHANES sample (American population) using DXA [59].”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 1×
“(4) and 2) ASM as a percentage of body weight (ASM/Wt), which was modified from the study of Janssen et al.”
MethodJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E. M., Goodpaster, B. H., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., & on Behalf of the Health, A. A. B. C. S. I. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.1.72 · Cited by 1,692
Body Composition in Healthy Aging
BAUMGARTNER, R. N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06498.x · Cited by 1,078
Sarcopenic obesity: A new category of obesity in the elderly
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., & Di Francesco, V. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.10.002 · Cited by 953 · cited 1×
“Second, previous studies used BMI or the percentage of fat mass for the definition of obesity to obtain a sufficient number of subjects within the group for statistical analysis (14).”
MethodSarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937 · cited 1×
“(1) showed that the prevalence of metabolic syndrome was highest in the group of nonsarcopenic obese subjects.”
BackgroundNew Criteria for `Obesity Disease' in Japan
Oda, E. (2006) · Circulation Journal · doi:10.1253/circj.70.150 · Cited by 783
Sarcopenic obesity and inflammation in the InCHIANTI study
Schrager, M. A., Metter, E. J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., & Ferrucci, L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00627.2006 · Cited by 594 · cited 1×
“These factors activate a vicious cycle leading to accelerated sarcopenia, additional weight gain largely in the form of fat, and ultimately to physical disability (1, 9-12).”
Background
Research works printed but not linked: 1
- World Health Organization Western Pacific Region, 2000, The Asia-Pacific perspective: redefining obesity and its treatment
Cited by
Items 301–400 of 593
Wu, M.-Y., Lim, W.-X., Cheng, Y., Chang, C.-D., Hsu, H., Lin, C., Chen, C., Chang, W.-C., Yu, C., Tsang, L. L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98399-6 · Cited by 18
Kuchay, M. S., Choudhary, N. S., Gagneja, S., Mathew, A., Bano, T., Kaur, P., Bahadur, B., Singh, M. K., Gill, H. K., Wasir, J. S., et al. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15595 · Cited by 17
Zeng, F., Huang, L., Zhang, Y., Hong, X., Weng, S., Shen, X., Zhao, F., & Yan, S. (2022) · Journal of Diabetes Research · doi:10.1155/2022/2202511 · Cited by 17
“proposed that sarcopenia be involved in the occurrence and development of CVD through mitochondrial dysfunction, oxidative stress, insulin resistance, inflammatory factors, and other mechanisms [46].”
BackgroundAssociation Between Low Relative Muscle Mass and the Risk of Colorectal Neoplasms
Jung, Y. S., Kim, N. H., Ryu, S., Park, J. H., Park, D. I., & Sohn, C. I. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000724 · Cited by 17
Sarcopenia among Adults with Cerebral Palsy in South Korea
Jeon, I., Bang, M. S., Lim, J., Shin, H., Leigh, J., Kim, K., Kwon, B. S., Jang, S., & Jung, S. H. (2019) · PM&R · doi:10.1002/pmrj.12134 · Cited by 17
“99 Brief Fatigue Inventory 18 (4-27) 17 (0-30) .”
Self-citationComparisons of different indices of low muscle mass in relationship with cardiometabolic disorder
Kim, J. Y., Oh, S., Park, H. Y., Jun, J. H., & Kim, H. J. (2019) · Scientific Reports · doi:10.1038/s41598-018-37347-3 · Cited by 18
Self-citationSpontaneous ketonuria and risk of incident diabetes: a 12 year prospective study
Kim, G., Lee, S., Lee, B., Kang, E. S., Soo, B., Ferrannini, E., Lee, Y., & Cho, N. H. (2019) · Diabetologia · doi:10.1007/s00125-019-4829-x · Cited by 19
Seko, T., Akasaka, H., Koyama, M., Himuro, N., Saitoh, S., Miura, T., Mori, M., & Ohnishi, H. (2019) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13805 · Cited by 17
Effect of obesity and type 2 diabetes on protein anabolic response to insulin in elderly women
Murphy, J., Chevalier, S., Gougeon, R., Goulet, E. D. B., & Morais, J. A. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.06.008 · Cited by 19
Kim, G., Lee, Y., Jeon, J. Y., Bang, H., Lee, B., Kang, E. S., Lee, I. K., Cha, B.-S., & Kim, C. S. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.09.002 · Cited by 17
Adiposity is inversely associated with strength in older adults with type 2 diabetes mellitus
Barrett, M., McClure, R., & Villani, A. M. (2020) · European Geriatric Medicine · doi:10.1007/s41999-020-00309-y · Cited by 17
“1 3 Although a number of studies have previously attempted to identify the prevalence of SO [34, 35], to the best of our knowledge, ours is the first study to explore diagnostic differences for identification of SO using the original and most recently revised diagnostic algorithm outlined by the EWGSOP.”
BackgroundMethodSarcopenic Obesity and Its Impact on Quality of Life: A Concise Review
Kumari, M., & Khanna, A. (2023) · Current Aging Science · doi:10.2174/1874609816666230525161020 · Cited by 16
Bae, J. H., Seo, J.-W., Li, X., Ahn, S., Sung, Y., & Kim, D. Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-64742-w · Cited by 17
“WC was used as the Korean abdominal obesity criterion ( ≥ 90 cm, men; ≥ 85 cm, women) 7,29,30 .”
MethodPang, Y., Li, M., Jiang, J., Chen, X. '., Fu, Y. H. H., Wang, C., He, Y., Zhao, Y., Wang, Y., Guan, X., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13071 · Cited by 15
“5 cm(2)/m(2) for females,(28) and visceral obesity was defined as VFI > 100 cm(2)/m(2) for both males and females.(29) Representative body composition measurements at the L3 level for patients with normal body composition parameters and patients with parameters consistent with sarcopenia and visceral obesity are prese…”
BackgroundKim, S. H., Kim, W. D., Yang, S., Kwon, S., & Choi, K. H. (2018) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001412 · Cited by 16
Xu, Y., Ma, X., Shen, Y., Gu, C., Tang, J., & Bao, Y. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.11.025 · Cited by 15
Scott, D. S., & Hirani, V. (2015) · European Geriatric Medicine · doi:10.1016/j.eurger.2015.11.009 · Cited by 21
Luo, Y., Shu, L., Wang, Y., Zhao, X., Han, M., Liu, Y., Xu, Y. J., & Han, B. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01909-z · Cited by 15
“Advancing research in these areas will contribute to a clearer understanding of the causal relationship between SO and CCVD, and provide a robust scienti fi c foundation for developing evidence-based risk assessment and intervention strategies in clinical practice.”
“Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”
Hanna, D. J., Jamieson, S. T., Lee, C. S., Pluskota, C. A., Bressler, N., Benotti, P. N., Khurana, S., Rolston, D. D. K., & Still, C. D. (2021) · Obesity Science & Practice · doi:10.1002/osp4.509 · Cited by 14
“7% in women.(29) However, when utilizing ASM/Wt, the prevalence increased to 35.”
BackgroundChang, C., Kuo, C., Lin, M., Wu, D., Lu, C., & Chu, N. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14429 · Cited by 14
Myostatin as a plausible biomarker for early stage of sarcopenic obesity
Ishibashi, C., Nakanishi, K., Nishida, M., Shinomiya, H., Shinzawa, M., Kanayama, D., Yamamoto, R., Kudo, T., Nagatomo, I., & Yamauchi‐Takihara, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-79534-5 · Cited by 16
Haines, M. S., Leong, A., Porneala, B. C., Zhong, V. W., Lewis, C. E., Schreiner, P. J., Miller, K. K., Meigs, J. B., & Carnethon, M. R. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.09.017 · Cited by 15
Koo, B. K. (2019) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2019.28.1.46 · Cited by 14
Cao, Y., Zhong, M., Zhang, Y., Zheng, Z., Liu, Y., Ni, X., Han, L., Song, M., Zhang, W., & Wang, Z. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s235335 · Cited by 14
“dard deviation (SD) below the sex-specific average value of skeletal muscle mass of the reference group.(16,23) Cao et al Dovepress”
BackgroundAnaphylaxis to parenteral thiamine (vitamin B1).
Morinville, V., Jeannet-Peter, N., & Hauser, C. (1998) · PubMed · Cited by 14
Chrysavgis, L., Mourelatou, N. G., Koloutsou, M. E., Rozani, S., & Cholongitas, Ε. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412130 · Cited by 16
“This condition contributes to an increased risk of metabolic diseases such as T2D and MASLD, reduces quality of life, and is associated with increased morbidity and mortality [61,62].”
Weng, X., Liu, S., Li, M., Zhang, Y., Zhang, Y., Liu, C., Zhu, J., & Hu, H. (2023) · Psychogeriatrics · doi:10.1111/psyg.13015 · Cited by 14
“Several studies have also demonstrated that older people with SO have a higher risk of cardiovascular disease, including hyperglycaemia, hypertension, hyperlipidaemia, and insulin resistance, 26,27 which is in accordance with the fi ndings of our study.”
ResultThe Association between Sarcopenic Obesity and DXA-Derived Visceral Adipose Tissue (VAT) in Adults
LORENZO, A. D., Itani, L., Ghoch, M. E., Frank, G., Santis, G. L. D., Gualtieri, P., & Renzo, L. D. (2024) · Nutrients · doi:10.3390/nu16111645 · Cited by 16
“SO was defined as the appendicular lean mass (ALM) (kg), divided by body weight (kg) (ALM/weight), as indicated in previous studies [28,29].”
MethodSarcopenia in Korea: Prevalence and Clinical Aspects
Kim, K. M., Lim, S. K., Choi, K. M., Kim, J. H., Yu, S. H., Kim, T. N., Song, W., Lim, J., Won, C. W., Yoo, H. J., et al. (2015) · Journal of the Korean Geriatrics Society · doi:10.4235/jkgs.2015.19.1.1 · Cited by 13
Self-citationSarcopenia and cardiovascular risk in physically active adult and elderly women
de Castro, E. A., Lima, L. M., Cerqueira, M. S., Gobbi, S., & Doimo, L. A. (2014) · Motriz Revista de Educação Física · doi:10.1590/s1980-65742014000100014 · Cited by 13
“More recent studies (Kim et al., 2011; Lim et al., 2010) consider sarcopenic obesity as the combination of factors adopted for predicting obesity and sarcopenia, with prevalence of 5.7% in women aged ≥ 65 years.”
BackgroundResultInfluentialLee, H., Chang, J. S., Ahn, J.-H., Kim, M. Y., Park, K., Ahn, Y., & Koh, S. B. (2021) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.21.387 · Cited by 14
“Simi - larly, Lim et al. [29] argued in 2010 that body weight adjust - ment was more useful for predicting metabolic disease than height adjustment.”
Self-citationThe Effect of Long-Term Hypogonadism on Body Composition and Morphometry of Aged Male Wistar Rats
Borbélyová, V., Šarayová, V., Renczés, E., Čonka, J., Janko, J., Šebeková, K., Stefikova, K., Ostatníková, D., & Celec, P. (2021) · Physiological Research · doi:10.33549/physiolres.934836 · Cited by 13
Park, C., Yoon, K. J., Lee, Y., Jin, S. M., Lee, S. H., & Kim, T. H. (2022) · Healthcare · doi:10.3390/healthcare10102022 · Cited by 16
“Some studies reported that in the condition of the co-existence of pre-sarcopenia and obesity, the risk of metabolic impairment and physical disability is higher than either pre-sarcopenia or obesity alone [16,17].”
BackgroundBang, E., Tanabe, K., Yokoyama, N., Chijiki, S., & Kuno, S. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.03.010 · Cited by 14
“Furthermore, sarcopenic obesity, defined as having low skeletal muscle mass in the presence of obesity (Baumgartner et al., 2004), is reportedly more closely associated with MetS than either sarcopenia or obesity alone (Lim et al., 2010).”
BackgroundSong, W., & Chang, Y. (2017) · Asia Pacific Allergy · doi:10.5415/apallergy.2017.7.4.185 · Cited by 13
Batitucci, G., Abud, G. F., Ortiz, G. U., Belisário, L. F., Travieso, S. G., Viliod, M. C. D. L., Venturini, A. C. R., & de Freitas, E. C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102460 · Cited by 13
O’Leary, M. F., Barreto, M., & Bowtell, J. L. (2019) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2019.1684417 · Cited by 13
Lee, T. Y., Jeon, Y., Kim, C. R., Kang, B. J., & Park, G. (2021) · Healthcare · doi:10.3390/healthcare9091197 · Cited by 13
“, larger muscle mass was inversely related to insulin sensitivity [9].”
BackgroundPowell, M., Lara, J., Mocciaro, G., Prado, C. M. M., Battezzati, A., Leone, A., Tagliabue, A., Amicis, R. S. D., Vignati, L., Bertoli, S., et al. (2016) · Clinical Obesity · doi:10.1111/cob.12165 · Cited by 12
“We specifically evaluated whether a high VAT:FFMI ratio was a better predictor of metabolic risk compared to the FM:FFM ratio based on the hypothesis that VAT, combined with low FFM, would be more closely linked to the pathogenesis of MetS.”
BackgroundMethodResultInfluentialSarcopenic Obesity in Non-Alcoholic Fatty Liver Disease—The Union of Two Culprits
Ali, S. E., & Nguyen, M. H. (2021) · Life · doi:10.3390/life11020119 · Cited by 14
Asociación entre obesidad sarcopénica con resistencia a la insulina y síndrome metabólico
Pérez‐Cruz, E., Castro-Martínez, D., & Guzmán, O. P. G. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2021.07.023 · Cited by 13
Shen, S., Chu, J., Cheng, L., Zeng, X., He, T., Xu, L., Li, J.-R., & Chen, X. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012140 · Cited by 15
Accumulation of intramuscular toxic lipids, a link between fat mass accumulation and sarcopenia
Capel, F., Pinel, A., & Walrand, S. (2019) · OCL · doi:10.1051/ocl/2019023 · Cited by 12
Dabak, M. R., Sevinç, E., Tüzün, S., & Gün, E. Ö. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.05.007 · Cited by 12
Xu, L., Zhang, H., Shi, M., Huang, Z.-X., Zhang, W., Chen, X.-D., Cai, Y.-Q., Zhu, G., Shen, X., & Chen, W.-J. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.07.032 · Cited by 14
Relationships between 25(OH)D concentration, sarcopenia and HOMA-IR in postmenopausal Korean women
Lee, J. H., Kim, S., Kim, M. K., Yun, B. H., Cho, S., Choi, Y. S., Lee, B. S., & Seo, S. K. (2018) · Climacteric · doi:10.1080/13697137.2017.1395410 · Cited by 11
Lee, I., Kim, S., & Kang, H. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01558-z · Cited by 12
Na, W., Kim, J., Chung, B., Jang, D.-J., & Sohn, C. (2020) · Nutrition Research and Practice · doi:10.4162/nrp.2020.14.4.352 · Cited by 11
Self-citationPredictors of Sarcopenia in an Obese Asian Population
Sung, M. J., Park, J. Y., Lee, H. W., Kim, B. K., Kim, D. Y., Ahn, S. H., & Kim, S. U. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1895232 · Cited by 11
“First, recent studies showed that higher BMI is associated with an increased risk of sarcopenia (2, 43, 44).”
BackgroundMusculoskeletal Disorders in Chronic Obstructive Airway Diseases: A Neglected Clinical Entity
Rao, C. M., Singh, P. K., Maikap, D., & Padhan, P. (2021) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.32.2.118 · Cited by 11
Multicompartment body composition analysis in older adults: a cross-sectional study
Venturini, A. C. R., Veras, L., Abdalla, P. P., dos Santos, A. P., Júnior, M. F. T., da Silva, L. S. L., Alves, T. C., Ferriolli, E., Romo-Pérez, V., Soidán, J. L. G., et al. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-03752-1 · Cited by 12
Hwang, J., & Park, S. (2024) · Healthcare · doi:10.3390/healthcare12060700 · Cited by 11
“…for sarcopenic obesity underscores the necessity for a better understanding of the intricate interplay between muscle and fat mass. Elevated triglyceride levels were identified as a factor contributing to sarcopenic obesity, consistent with findings from prior research on sarcopenic obesity [24–26].”
BackgroundResultSkeletal Muscle Mass as a Predictor of Mortality in the Elderly Population
Jung, H., Kim, S. W., Chin, H. J., Kim, C., & Kim, K. I. (2013) · Korean Journal of Medicine · doi:10.3904/kjm.2013.85.2.167 · Cited by 11
“다른 한 연구에서는 한 국의 지역사회 거주 노인에서 대사 증후군과 ASM/wt가 더 연관되어 있다는 보고를 하였다[22].”
Self-citationKim, S. Y., Min, J., Lee, H. S., Kwon, K., Yoo, J., & Won, C. W. (2018) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.18.0038 · Cited by 11
Kim, I., Son, K., Jeong, S. J., & Lim, H. (2022) · Nutrients · doi:10.3390/nu14183816 · Cited by 14
“Hand-grip-strength-to-weight ratio (HGSWR) was calculated as HGS divided by weight (kg) and multiplied by 100 [27].”
MethodXu, Y., Hu, T., Shen, Y., Wang, Y., Ma, X., & Bao, Y. (2022) · The journal of nutrition health & aging · doi:10.1007/s12603-022-1871-z · Cited by 11
Association between obesity with low muscle mass and dialysis mortality
Wu, H., Tseng, S.-F., Wang, W., Chen, H., & Lee, L. (2017) · Internal Medicine Journal · doi:10.1111/imj.13553 · Cited by 11
“Several factors such as cardiovascular disease, infection and advanced age were identified as aetiologies of mortality for those undergoing dialysis.4,5 Sarcopenia, defined as a syndrome characterised by progressive and generalised loss of skeletal muscle mass and strength, is common in those with chronic obstructive…”
ResultInfluentialDoes Protein Intake Affect Metabolic Risk Factors among Older Adults in Korea?
Oh, C., & No, J.-K. (2017) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2017.26.4.266 · Cited by 11
Alves Guimarães, M. S., Araújo dos Santos, C., da Silva Castro, J., Juvanhol, L. L., Canaan Rezende, F. A., Martinho, K. O., & Ribeiro, A. Q. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.11.004 · Cited by 10
Inoue, K., Fujie, S. J., Kurose, S., Miyauchi, T., Sanada, K., Kimura, Y., & Iemitsu, M. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00573.2023 · Cited by 10
Effects of Sarcopenic Obesity on Cardiovascular Disease and All-Cause Mortality
Atkins, J. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-810422-4.00007-5 · Cited by 11
Hong, J., Shin, W., Lee, J.-W., & Kim, Y. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0011 · Cited by 10
“24 In this study, we identified that insulin resistance-related indices, like waist circumference, BMI, and HOMA-IR, were much higher in the group with NAFLD.”
Kim, J. H., Kim, H. L., Battushig, B., & Yoo, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254141 · Cited by 10
Self-citationRelationship between creatinine to body weight ratios and diabetes mellitus: A Chinese cohort study
Chen, Z., Zou, Y., Yang, F., Ding, X. H., Cao, C., Hu, H., & Wang, X. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13248 · Cited by 10
“Skeletal muscle is one of the main target organs of insulin, which plays a significant role in maintaining glucose homeostasis.(5,6) Decrease in the skeletal muscle mass leads to a reduction in systemic glucose uptake.”
BackgroundHe, J. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00776-8 · Cited by 10
“In addition, muscle mass is negatively associated with IR and prediabetes, and IR is a critical pathogenic mechanism of diabetes [22].”
BackgroundPark, H., Jun, S., Lee, H. A., Kim, H. S., Hong, Y. S., & Park, H. (2023) · Metabolites · doi:10.3390/metabo13010133 · Cited by 12
“In adults, sarcopenic obesity has a stronger association with MetS risk than either obesity or sarcopenia alone [37,38].”
BackgroundCarcelén‐Fraile, M. D. C., Aibar‐Almazán, A., Afanador-Restrepo, D. F., Rivas-Campo, Y., Rodríguez-López, C., Carcelén-Fraile, M. D. M., Castellote‐Caballero, Y., & Hita‐Contreras, F. (2023) · Life · doi:10.3390/life13030648 · Cited by 14
“This significant relationship may be explained, as having low muscle mass may mean that a person is more susceptible to insulin resistance [41].”
BackgroundBang, E., Tanabe, K., Yokoyama, N., Chijiki, S., Tsuruzono, T., & Kuno, S. (2018) · European Journal of Applied Physiology · doi:10.1007/s00421-018-3812-4 · Cited by 10
“2004), is associated with a higher incidence of metabolic syndrome than obesity alone (Lim et al. 2010).”
BackgroundDefining sarcopenia in terms of skeletal health
Kim, J. H., Hong, A. R., Choi, H. J., Ku, E. J., Lee, J., Cho, N. H., & Shin, C. S. (2018) · Archives of Osteoporosis · doi:10.1007/s11657-018-0511-z · Cited by 10
Self-citationGastrointestinal hemorrhage complicating systemic neurofibromatosis.
Melin, M. M., Grotz, R. L., & Nivatvongs, S. (1994) · PubMed · Cited by 11
Wei, W.-X., Mao, Z. F., Chen, M., & Meng, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1500915 · Cited by 13
Serum calcium levels and the risk of sarcopenia in young adults: insights from NHANES 2011–2018
Jiang, J., Chen, G., Li, Y., Zhao, Q., & Chen, Z. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1526879 · Cited by 9
Xia, L.-F., Li, J., Tian, G.-S., Jiang, W., Li, Y.-S., Lin, C.-Y., Qiu, H.-N., Wu, F., Wang, J.-J., Li, C., et al. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s450225 · Cited by 10
Morioka, T., Mori, K., Motoyama, K., & Emoto, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-55720-3_14 · Cited by 11
dos Santos, V. R., Christófaro, D. G. D., Gomes, I. C., Viezel, J., Júnior, I. F. F., & Gobbo, L. A. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.12.019 · Cited by 9
“In a study with Koreans older people [28], no statistically significant differences were observed in the TG variable between the four groups analysed, although the high fat group presented a higher mean value compared to the other groups.”
BackgroundResultPoor Physical Function as a Marker of Sarcopenia in Adults with Class II/III Obesity
Stoklossa, C. J., Ghosh, S. S., Forhan, M. A., Sharma, A. M., Terada, T., Siervo, M., Baracos, V. E., Padwal, R. S., Hung, P. A., Sawyer, M. B., et al. (2017) · Current Developments in Nutrition · doi:10.3945/cdn.117.001743 · Cited by 11
“From the 5 sarcopenia definitions explored (Table 1), 2 were significantly correlated with items of difficulty with ADLs: ASM/weight x 100 (%) (21, 22) (r = –0.”
Lim, S. K., Min, S. H., Lee, J. H., Kim, L.-K., Lee, D., Lee, J.-E., Kim, K. M., Lee, S., Park, K., & Lee, Y. J. (2019) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2019.28.2.118 · Cited by 9
Self-citationHong, J., Shin, W., Lee, J.-W., Lee, S., & Kim, Y. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0106 · Cited by 9
“31 According to a Korean cohort study, the prevalence of sarcopenia was 16.7% in men and 5.7% in women when measured by ASM/Ht, but 35.1% in men and 48.1% in women when measured by ASM/Wt. 21 For the ASM/BMI index by the National Institutes of Health (NIH), 23 a previous cohort study showed that the limitation of the…”
InfluentialHwang, J., & Moon, I.-Y. (2023) · Journal of the Korean Society of Physical Medicine · doi:10.13066/kspm.2023.18.3.11 · Cited by 9
Li, T., Cao, C., Xuan, X., Liu, W., Xiao, X., & Wei, C. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01518-9 · Cited by 9
“Skeletal muscle is one of insulin’s primary target organs and plays an important role in maintaining glucose homeostasis [11, 12].”
BackgroundNakano, R., Takebe, N., Ono, M., Hangai, M., Nakagawa, R., Yashiro, S., Murai, T., Nagasawa, K., Takahashi, Y., Satoh, J., et al. (2017) · Obesity Science & Practice · doi:10.1002/osp4.97 · Cited by 8
“Because subjects with diabetes are thought to be extremely vulnerable to impairments associated with senescence, such as atherosclerosis, bone fracture and cognitive dysfunction (9), optimally managing diabetes in the elderly population has become a major concern in Japan as this nation faces the consequences of a sup…”
Kim, J., Jeong, K., Lim, S., Lee, S. W., & Baek, Y.-H. (2023) · Metabolites · doi:10.3390/metabo14020130 · Cited by 8
“Obesity Risk Factors in Sarcopenic Obesity Prevalence Our results are consistent with those of other studies on sarcopenia in the South Korean population [33,34] using the ASM (”
ResultSelf-citationHe, J., Gao, L., & Mai, L. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2251592 · Cited by 9
Lou, Y., Xie, Y., Jiang, Q., Huang, S., Wang, X., Wang, L., Wang, H., & Cao, S. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16016 · Cited by 8
“28 Jun et al. found that pre-SO significantly increased incident diabetes risk (adjusted HR = 1.57; 95% CI: 1.42 – 1.73) compared with normal body composition, pre-sarcopenia only, or abdominal obesity only.”
InfluentialStruszczak, L., Hickson, M., McClelland, I., Metcalf, B. S., Barreto, M., Torquati, L., Fulford, J., Allen, R., Hulme, C. T., O’Leary, M. F., et al. (2024) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2024.100429 · Cited by 9
“Epidemiological evidence indicates that protein intake is negatively associated with both functional capacity and sarcopenia [15], and therefore decreases risk of cardiovascular [16] and metabolic diseases [17] and incidence of falls and fractures [18].”
Li, Y., Wang, Y., Gao, J., Meng, T., & Yin, H. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.04.003 · Cited by 9
Association between Skeletal Mass Indices and Metabolic Syndrome in Brazilian Adults
de Carvalho, C. J., Longo, G. Z., Kakehasi, A. M., Pereira, P. F., Segheto, K. J., Juvanhol, L. L., & Ribeiro, A. Q. (2020) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2020.02.003 · Cited by 10
Skeletal muscle mass and risk of advanced adenoma in surveillance colonoscopy
Yoo, K. M., Yang, H., Park, S., Jung, Y. S., Park, J. H., Park, D. I., & Sohn, C. I. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15082 · Cited by 9
Park, J.-M., Kim, Y.-H., Lee, S.-Y., & Kim, A. (2021) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2021.26.4.380 · Cited by 8
“, 2014), metabolic syndrome (Lim et al., 2010), frailty (Morley et al.”
BackgroundChen, Y., Wen, W., Mai, Z., Wang, M., Chen, H., & Sun, J. M. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13435 · Cited by 8
Takayama, M., Azuma, K., Shimizu‐Hirota, R., Makino, K., Seino, T., Yoshida, T., Kashiwagi, K., Hirose, H., Inoue, N., & Iwao, Y. (2018) · Health Evaluation and Promotion · doi:10.7143/jhep.45.573 · Cited by 8
Hong, C., Baek, J. Y., Lee, J. W., Lee, J. H., Lee, K., Park, T.-J., & Kim, J. (2020) · Korean Journal of Family Medicine · doi:10.4082/kjfm.19.0032 · Cited by 8
Self-citationWu, S., & Chen, W. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14607 · Cited by 8
Park, Y. J., & Lee, Y. M. (2021) · Asia-Pacific Journal of Oncology Nursing · doi:10.4103/apjon.apjon-2116 · Cited by 8
Self-citationTakayama, M., Azuma, K., Hayashi, K., Shimizu‐Hirota, R., Makino, K., Bessho, R., Yoshida, T., Kashiwagi, K., Hirose, H., Inoue, N., et al. (2017) · Health Evaluation and Promotion · doi:10.7143/jhep.44.587 · Cited by 8
Batsis, J. A., Petersen, C. L., Crow, R. S., Cook, S. B., Stevens, C. J., Seo, L. M., Brooks, E., & MacKenzie, T. A. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.10.032 · Cited by 9
Yılmaz, Ö., & Bahat, G. (2019) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13609 · Cited by 8
Construction of a prediction model for sarcopenic obesity based on machine learning
Xu, M., Liu, J., Hu, S., Luan, T., Duan, Y., Wang, A., Cui, Z., Zhou, J., & Mao, Y. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1576338 · Cited by 7
Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
Abenavoli, L., Statsenko, M., Scarlata, G. G. M., Morano, D., Myazin, R. G., & Emelyanov, D. (2024) · Livers · doi:10.3390/livers4040035 · Cited by 9
“A 2010 study first identified the link between sarcopenia and MASLD, noting higher MASLD prevalence in individuals with sarcopenia, especially those with elevated BMI [60].”
Luo, Y., Chen, X., Liu, Y., Xu, Y. J., Liu, G., & Han, B. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1581146 · Cited by 7
Metadata
- Authors
- Lim, S., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Lim, J. Y., Park, K. S., & Jang, H. C.
- Affiliations
- Seoul National University (KR)
- Corresponding author
- Jang, Hak Chul
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-05-11
- Volume
- 33
- Issue
- 7
- Pages
- 1652-1654
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890376
- OpenAlex
- W2055418044
- Cited by
- 588
- References
- 17
- Citations by year
- 2026: 16 · 2025: 27 · 2024: 43 · 2023: 38 · 2022: 48 · 2021: 50 · 2020: 41 · 2019: 50 · 2018: 48 · 2017: 35 · 2016: 50 · 2015: 50 · 2014: 31 · 2013: 26 · 2012: 23
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- American Diabetes Association
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- sarcopenic obesity, sarcopenia, obesity, metabolic syndrome, prevalence, older adults, appendicular skeletal muscle mass, visceral fat area, insulin resistance, sex differences
- MeSH terms
- Aged, Aged, 80 and over, Aging, Female, Humans, Insulin Resistance, Longitudinal Studies, Male, Obesity, Risk Factors, Prevalence, Logistic Models, Sex Distribution, Metabolic Syndrome, Asian People, Sarcopenia, Republic of Korea
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.